Key Takeaways
- • Tombot closed a $7 million Series A3 funding round, marking continued capital deployment in the health and wellness robotics sector.
- • The round attracted four institutional investors: Caduceus Capital Partners, Wavemaker 360, the Lutheran Foundation for Long Term Living, and Florida Community Health Network, signaling diversified backer confidence spanning healthcare and philanthropic sectors.
- • Tombot positions itself as a leader in robotic companion animals for health and wellness applications, addressing an emerging category within consumer robotics and elder care markets.
- • The Series A3 designation indicates this is an advanced early-stage round, suggesting the company has achieved meaningful product-market validation prior to this capital infusion.
Summary
Tombot announced the successful closing of a $7 million Series A3 financing round on June 26, 2026, representing a significant capital milestone for the Los Angeles-based robotics company. The funding reflects investor appetite for specialized robotics applications in health and wellness verticals, particularly as demographic trends drive institutional interest in aging care solutions and companion technologies.
The round's investor syndicate encompasses both traditional venture capital and mission-aligned institutional capital. Caduceus Capital Partners and Wavemaker 360 bring venture expertise, while the Lutheran Foundation for Long Term Living and Florida Community Health Network represent healthcare-focused institutional investors with direct incentives in wellness and elder care outcomes. This composition suggests the market recognizes Tombot's technology as addressing both commercial opportunity and healthcare delivery gaps.
Tombot's focus on robotic companion animals places the company at the intersection of consumer robotics, gerontology, and digital health—sectors experiencing significant institutional investment momentum. The Series A3 designation indicates the company has progressed beyond early proof-of-concept and has likely demonstrated sufficient traction to attract repeat and new institutional capital. The diversity of investor backgrounds underscores the versatility of the company's value proposition across venture, healthcare operations, and philanthropic investment mandates.
The round's investor syndicate encompasses both traditional venture capital and mission-aligned institutional capital. Caduceus Capital Partners and Wavemaker 360 bring venture expertise, while the Lutheran Foundation for Long Term Living and Florida Community Health Network represent healthcare-focused institutional investors with direct incentives in wellness and elder care outcomes. This composition suggests the market recognizes Tombot's technology as addressing both commercial opportunity and healthcare delivery gaps.
Tombot's focus on robotic companion animals places the company at the intersection of consumer robotics, gerontology, and digital health—sectors experiencing significant institutional investment momentum. The Series A3 designation indicates the company has progressed beyond early proof-of-concept and has likely demonstrated sufficient traction to attract repeat and new institutional capital. The diversity of investor backgrounds underscores the versatility of the company's value proposition across venture, healthcare operations, and philanthropic investment mandates.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.